These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist. McIsaac RL; Johnston BJ; Flannery MC J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with impromidine, a highly specific H2-receptor agonist. Bangerter U; Schlup M; Liechti M; Häcki WH; Halter F Digestion; 1981; 22(4):196-202. PubMed ID: 6458522 [TBL] [Abstract][Full Text] [Related]
6. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Hirschowitz BI Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436 [TBL] [Abstract][Full Text] [Related]
7. Histamine H-2 receptor stimulation and inhibition of pepsin secretion in the dog. Hirschowitz BI; Rentz J; Molina E J Pharmacol Exp Ther; 1981 Sep; 218(3):676-80. PubMed ID: 6455514 [TBL] [Abstract][Full Text] [Related]
8. Effect of mepyramine on the untoward side-effects of impromidine. Bank L; Marks IN; Lipschitz E; Bortz D S Afr Med J; 1984 Aug; 66(7):262-4. PubMed ID: 6235604 [TBL] [Abstract][Full Text] [Related]
9. Use of impromidine to define specific histamine H-2 effects on gastric secretion, heart rate and blood pressure in conscious dogs. Molina E; Rentz J; Hirschowitz BI J Pharmacol Exp Ther; 1980 Sep; 214(3):483-7. PubMed ID: 6447202 [TBL] [Abstract][Full Text] [Related]
10. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. Jones DB; Howden CW; Burget DW; Silletti C; Hunt RH Gut; 1988 Jul; 29(7):890-3. PubMed ID: 2969357 [TBL] [Abstract][Full Text] [Related]
11. Morphology and function of the parietal cells after proximal selective vagotomy in duodenal ulcer patients. Aärimaa M; Söderström KO; Kalimo H; Inberg M; Nevalainen T Scand J Gastroenterol; 1984 Sep; 19(6):787-97. PubMed ID: 6515317 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori influence on gastric acid secretion in duodenal ulcer patients diagnosed for the first time. Testino G; Cornaggia M; De Iaco F Panminerva Med; 2002 Mar; 44(1):19-22. PubMed ID: 11887086 [TBL] [Abstract][Full Text] [Related]
13. Interdigestive gastroduodenal motor activity in subjects with increased gastric acid secretion. Bortolotti M; Barbara L Digestion; 1988; 41(3):156-60. PubMed ID: 2976007 [TBL] [Abstract][Full Text] [Related]
14. Parietal cell hyperactivity is not due to Helicobacter pylori infection in patients with duodenal ulcer. Valenzuela M; Martín-Ruiz JL; Cahallero-Plasencia AM; Alvarez-Cienfuegos I; Nogales FF; Guilarte J; Peña JF Am J Gastroenterol; 1996 Oct; 91(10):2114-9. PubMed ID: 8855732 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
16. Physiopathological heterogeneity of the duodenal mechanisms that inhibit gastric acid secretion in duodenal ulcer patients. Sainz R; Lanas A; Martinez T; Montoro M; Bueno J Am J Gastroenterol; 1985 Sep; 80(9):673-7. PubMed ID: 4036945 [TBL] [Abstract][Full Text] [Related]
17. Gastric mucosal blood flow and acid secretory changes in man with impromidine: a new specific histamine-H2-receptor agonist. McIsaac RL; Johnston BJ; Fielding LP Gut; 1981 Jul; 22(7):529-33. PubMed ID: 6455334 [TBL] [Abstract][Full Text] [Related]